New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Oncology January 23,2024
Study finds 'startling' inequities in end-of-life opioid treatment

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in
Oncology January 23,2024
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Oncology January 23,2024
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Oncology January 23,2024
Study finds younger kidney cancer survivors at significant risk for heart problems

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si
Oncology January 23,2024
Study finds younger kidney cancer survivors at significant risk for heart problems

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si
Oncology January 23,2024
COVID vaccination improves effectiveness of cancer treatment, study finds

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi
Oncology January 23,2024
COVID vaccination improves effectiveness of cancer treatment, study finds

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi
Oncology January 23,2024
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Oncology January 23,2024
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Oncology January 23,2024
Study finds use of methotrexate is associated with an increased risk of skin cancer

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal
Oncology January 23,2024
Study finds use of methotrexate is associated with an increased risk of skin cancer

Study finds use of methotrexate is associated with an increased risk of skin cancer

byUniversity of GothenburgRisk of basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous malignant melanoma according to cumulative methotrexate dose for all patients. BCC basal
Oncology January 23,2024
GI symptoms persist in older female colorectal cancer survivors, study finds

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba
Oncology January 23,2024
GI symptoms persist in older female colorectal cancer survivors, study finds

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba
Oncology January 23,2024
Study uncovers evidence that fibroblasts may be directly involved in development of gastric cancer

Study uncovers evidence that fibroblasts may be directly involved in development of gastric cancer

by Bill Snyder,Vanderbilt UniversityCredit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.04.038Fibroblast cells play key roles in the repair of damaged tissue and in pathologica
Oncology January 23,2024
Study uncovers evidence that fibroblasts may be directly involved in development of gastric cancer

Study uncovers evidence that fibroblasts may be directly involved in development of gastric cancer

by Bill Snyder,Vanderbilt UniversityCredit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.04.038Fibroblast cells play key roles in the repair of damaged tissue and in pathologica
Oncology January 23,2024
Dietary supplement helps combat resistance in breast cancer, finds study

Dietary supplement helps combat resistance in breast cancer, finds study

byUniversity of BaselCredit: Unsplash/CC0 Public DomainMany cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medicatio
Oncology January 23,2024
Dietary supplement helps combat resistance in breast cancer, finds study

Dietary supplement helps combat resistance in breast cancer, finds study

byUniversity of BaselCredit: Unsplash/CC0 Public DomainMany cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medicatio
Oncology January 23,2024
Antibiotics after breast cancer linked to poorer survival, study finds

Antibiotics after breast cancer linked to poorer survival, study finds

by Krista Conger,Stanford University Medical CenterLandmarking analysis to evaluate the impact of antimicrobial exposure on survival over time on N = 772 independent patients. Data were presente
Oncology January 23,2024
Antibiotics after breast cancer linked to poorer survival, study finds

Antibiotics after breast cancer linked to poorer survival, study finds

by Krista Conger,Stanford University Medical CenterLandmarking analysis to evaluate the impact of antimicrobial exposure on survival over time on N = 772 independent patients. Data were presente
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com